Association between pioglitazone use and head and neck cancer: Population-based case-control study

Tzong Hann Yang, Sudha Xirasagar, Yen Fu Cheng, Chuan Song Wu, Yi Wei Kao, Ben Chang Shia, Herng Ching Lin

Research output: Contribution to journalArticle

Abstract

Background: This study aimed to evaluate the association between pioglitazone use and the occurrence of head and neck cancer. Methods: Data for this case-control study were retrieved from the Taiwan National Health Insurance Research Database. A total of 21 464 diabetic patients newly diagnosed with head and neck cancers were identified. We used propensity score matching to select 64 392 comparison patients (3:1 ratio). Multiple logistic regression modeling was used to examine the association of head and neck cancer with pioglitazone use in the 5 years preceding the cancer diagnosis. Results: Bivariate analysis showed a significant difference in the prevalence of prior using pioglitazone between cases and controls (19.3% vs 18.5%, P <.001) was observed. Multiple regression analysis showed adjusted odds of pioglitazone use of 1.06 (95% CI: 1.02-1.10) among cases relative to controls. Conclusions: Prior pioglitazone use was associated with oral cavity cancer.

Original languageEnglish
JournalHead and Neck
DOIs
Publication statusAccepted/In press - Jan 1 2019

Keywords

  • diabetes
  • epidemiology
  • head and neck cancer
  • oral cavity cancer
  • pioglitazone

ASJC Scopus subject areas

  • Otorhinolaryngology

Fingerprint Dive into the research topics of 'Association between pioglitazone use and head and neck cancer: Population-based case-control study'. Together they form a unique fingerprint.

  • Cite this